Long-term changes in anemia-related parameters among Japanese dialyzed patients assessed by newly developed web-based system.

Published on Jul 2, 2021in Therapeutic Apheresis and Dialysis1.041
· DOI :10.1111/1744-9987.13705
Yukio Maruyama18
Estimated H-index: 18
(Jikei University School of Medicine),
Takahito Niikura4
Estimated H-index: 4
(Jikei University School of Medicine)
+ 2 AuthorsTakashi Yokoo28
Estimated H-index: 28
(Jikei University School of Medicine)
Anemia treatment is crucial in the management of dialyzed patients. Although Hb and serum ferritin levels are commonly used as indicators for treatment, these values change over time due to changes in policy, drugs for treating anemia, and target levels suggested by clinical guidelines. To clarify long-term changes in anemia-related parameters in Japan, we extracted annual patient data from a newly developed web-based system by the Japanese Society for Dialysis Therapy, the Web-based Analysis of Dialysis Data Archives system. Hb levels gradually increased from 2008 to 2019. Serum ferritin levels and transferrin saturation tended to increase between 2012 and 2019. Although these changes were found in all dialyzed patients, these were more pronounced in patients on peritoneal dialysis. We believe that our results can contribute to a better understanding of the results of clinical studies assessing the effects of treatment for anemia on clinical outcomes among dialyzed patients.
📖 Papers frequently viewed together
3 Citations
#1Yukio Maruyama (Jikei University School of Medicine)H-Index: 18
#2Eiichiro Kanda (Kawasaki Medical School)H-Index: 16
Last. Kosaku NittaH-Index: 61
view all 7 authors...
BACKGROUND The prevalence and severity of anemia differ between diabetic and non-diabetic patients. We investigated whether the effect of hemoglobin (Hb) on patient outcome was affected by the presence or absence of diabetes among Japanese patients receiving chronic hemodialysis (HD). METHODS We enrolled 149,308 patients from a nationwide dialysis registry in Japan at the end of 2012 (mean age, 67.6 ± 12.3 years; male, 61.7%; diabetes, 43.5%; median dialysis duration, 65 months) who underwent th...
2 CitationsSource
#1Rachel L. Perlman (UM: University of Michigan)H-Index: 10
#2Junhui ZhaoH-Index: 8
Last. Jeffrey PerlH-Index: 27
view all 12 authors...
Background:The optimal treatment for managing anemia in peritoneal dialysis (PD) patients and best clinical practices are not completely understood. We sought to characterize international variations in anemia measures and management among PD patients.Methods:The Peritoneal Dialysis Outcomes and Practice Patterns Study (PDOPPS) enrolled adult PD patients from 6 countries from 2014 to 2017. Hemoglobin (Hb), ferritin levels, and transferrin saturation (TSAT), as well as erythropoiesis stimulating ...
8 CitationsSource
#1Angelo KaraboyasH-Index: 21
#2Hal Morgenstern (UM: University of Michigan)H-Index: 86
Last. Bruce M. Robinson (UM: University of Michigan)H-Index: 38
view all 10 authors...
Background: The Kidney Disease: Improving Global Outcomes guidelines have cautioned against administering intravenous (IV) iron to hemodialysis patients with high serum ferritin levels due to safety concerns, but prior research has shown that the association between high ferritin and mortality could be attributed to confounding by malnutrition and inflammation. Our goal was to better understand the ferritin-mortality association and relative influence of IV iron and inflammation in the USA, wher...
28 CitationsSource
#1Tadao Akizawa (Showa University)H-Index: 62
#2Hiroyuki Okumura (Astellas Pharma)H-Index: 3
Last. Julie DoreyH-Index: 2
view all 6 authors...
: Anemia is a common complication for patients with chronic kidney disease (CKD) and is associated with cardiovascular comorbidities and reduced quality of life. The incidence of anemia increases as kidney function declines and affects approximately 32% of Japanese patients with stage 3-5 CKD. This review examined the current literature on anemia in CKD patients in Japan to provide an overview of the burden of anemia in CKD. Medline, Embase, and Igaku Chuo Zasshi databases were searched to ident...
25 CitationsSource
#1Hiroyasu YamamotoH-Index: 20
#2Shinichi Nishi (Kobe University)H-Index: 47
Last. Hirokazu Honda (Showa University)H-Index: 16
view all 19 authors...
Renal anemia is a complication of chronic kidney disease. Guidelines for safe and effective treatment in patients with renal anemia are needed. The Japanese Society for Dialysis Therapy (JSDT) published guidelines for the treatment of renal anemia in chronic hemodialysis patients in 2004 and in hemodialysis, peritoneal dialysis, predialysis, and pediatric patients in 2008. These two publications provide excellent guidance with respect to clinical practice issues, including the definition and dia...
87 CitationsSource
#1Wanning Wang (JLU: Jilin University)H-Index: 6
#2Wenlong Zhang (JLU: Jilin University)H-Index: 4
Last. Zhonggao Xu (JLU: Jilin University)H-Index: 8
view all 6 authors...
AbstractThe aim of this meta-analysis was to evaluate the effect of peritoneal dialysis (PD) and hemodialysis (HD) on renal anemia (RA) in renal disease patients by a meta-analysis. Relevant studies published before June 2015 were searched. Pooled odds ratio (OR) with 95% confidence interval (CI) was used to evaluate the effect of HD and PD on RA based on five indexes: hemoglobin, ferritin, transferrin saturation index, serum albumin, and parathyroid hormone. Sensitivity analysis and publication...
7 CitationsSource
#1Yukio Maruyama (Jikei University School of Medicine)H-Index: 18
#2Keitaro Yokoyama (Jikei University School of Medicine)H-Index: 29
Last. Yoshiharu TsubakiharaH-Index: 51
view all 6 authors...
Background/Aims Monitoring of serum ferritin levels is widely recommended in the management of anemia among patients on dialysis. However, associations between serum ferritin and mortality are unclear and there have been no investigations among patients undergoing peritoneal dialysis (PD).
20 CitationsSource
A nationwide statistical survey of 4279 dialysis facilities was conducted at the end of 2012, among which 4238 responded (99.0%). The number of new dialysis patients was 38 055 in 2012. Since 2008, the number of new dialysis patients has remained almost the same without any marked increase or decrease. The number of dialysis patients who died in 2012 was 30 710; a slight decrease from 2011 (30 743). The dialysis patient population has been growing every year in Japan; it was 310 007 at the end o...
104 CitationsSource
#1Keitaro Yokoyama (Jikei University School of Medicine)H-Index: 29
#2Takashi AkibaH-Index: 67
Last. Hideki HirakataH-Index: 57
view all 8 authors...
Abstract Objective JTT-751 is a novel phosphate binder containing ferric citrate as the active ingredient. This study investigated long-term safety and efficacy of JTT-751 for hyperphosphatemia in patients receiving hemodialysis. Design and Methods This was 52-week, phase 3, multicenter, open-label, dose titration, long-term study. All patients were receiving thrice-weekly hemodialysis for ≥3 months before the initiation of the study. JTT-751 was given at titrated doses between 1.5 and 6.0 g/day...
38 CitationsSource
#1Alan S. Kliger (Yale University)H-Index: 53
#2Robert N. FoleyH-Index: 94
Last. Lynda A. Szczech (Durham University)H-Index: 60
view all 7 authors...
The 2012 KDIGO (Kidney Disease: Improving Global Outcomes) Clinical Practice Guideline for Anemia in Chronic Kidney Disease provides clinicians with comprehensive evidence-based recommendations to improve patient care. In this commentary, we review these recommendations and the underlying evidence. Most recommendations are well reasoned. For some, the evidence is unclear and recommendations require some qualification. While the KDIGO guideline stresses the potential risks of intravenous iron the...
139 CitationsSource
Cited By0